CLINICAL_TRIALS
trial_result
· 2020-06-11
Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes [Phase 2]
Summary
Phase 2 trial update on closed-loop glucose control (artificial pancreas) for 12 days in adults with Type 1 Diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED